文献速递临床试验与 GCP真实世界研究与卫生经济

多发性硬化症严重疲劳:混合与面对面认知行为疗法的非劣效性及强化课程长期效果研究方案

Testing non-inferiority of blended versus face-to-face cognitive behavioural therapy for severe fatigue in patients with multiple sclerosis and the effectiveness of blended booster sessions aimed at improving long-term outcome following both therapies: study protocol for two observer-blinded randomized clinical trials.
PubMed 文献 · Trials · 2020-01-20

本研究包含两项随机临床试验:首先在166例严重疲劳的多发性硬化症患者中检验混合认知行为疗法(MS Fit)相比面对面认知行为疗法的非劣效性,主要终点为基线后20周;随后再次随机分配患者接受或未接受基于互联网的强化课程(MS Stay Fit),主要终点为基线后52周,评估其对长期疲劳结局的效果。

要点

  • MS Fit为基于有效面对面方案开发的混合CBT,旨在提高治疗可及性。
  • 第一项试验为非劣效性多中心随机对照试验,样本量166例。
  • 第二项试验评估MS Stay Fit强化课程对长期疲劳结局的效果。

核心结论

  • 若MS Fit不劣于面对面CBT,将改善该治疗的可及性。
  • 研究旨在检验MS Stay Fit能否改善CBT对MS相关疲劳的长期效果。

研究设计与样本

  • 第一项为观察者盲法、非劣效性多中心随机对照试验,纳入166例严重疲劳的MS患者,按1:1随机分配至面对面CBT或混合CBT(MS Fit)。
  • 第二项在治疗后评估后再次按1:1随机分配患者至MS Stay Fit(治疗后2和4个月各一次强化课程)或无强化课程。

关键数值与推荐

  • 第一项试验主要终点为基线后20周。
  • 第二项试验主要终点为基线后52周。
  • 两项研究的主要结局指标均为 Checklist Individual Strength(CIS20r)的疲劳严重程度子量表。
  • 结局评估时间点为基线(T0)、治疗结束(T20)、39周和52周(T39和T52)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cognitive behavioural therapy (CBT) has been found to be effective in reducing fatigue severity in MS patients directly following treatment. However, long-term effects are inconsistent leaving room for improvement. In addition, individual face-to-face CBT draws heavily on limited treatment capacity, and the travel distance to the treatment centre can be burdensome for patients. Therefore, we developed "MS Fit", a blended CBT for MS-related fatigue, based on a face-to-face CBT protocol found effective in a previous study, and "MS Stay Fit", internet-based booster sessions to improve long-term effectiveness of CBT for MS-related fatigue. This article presents the protocol of two randomised clinical trials (RCTs) conducted within one study investigating (1) the non-inferiority of MS Fit compared with evidence-based face-to-face CBT for MS-related fatigue and (2) the effectiveness of MS Stay Fit on the long-term outcome of fatigue compared with no booster sessions. METHODS/DESIGN: The first part of this study is an observer-blinded non-inferiority multicentre RCT, in which 166 severely fatigued MS patients will be randomly assigned (1:1 ratio, computer-generated sequence) to either face-to-face CBT or blended CBT (MS Fit) for fatigue. The primary endpoint is at 20 weeks after baseline. After this post-treatment assessment, patients will be randomly assigned again (1:1 ratio, computer generated sequence) to either MS Stay Fit consisting of two booster sessions at 2 and 4 months after end of treatment or no booster sessions. The primary endpoint of the second study is 52 weeks after baseline. Primary outcome measure in both studies is fatigue severity assessed with the fatigue severity subscale of the Checklist Individual Strength (CIS20r). Outcomes will be assessed at baseline (T0), at the end of treatment (T20), and after 39 and 52 weeks (T39 and T52). DISCUSSION: If MS Fit is found to be non-inferior to face-to-face CBT, it will improve the accessibility of this treatment. In addition, the study aims to test whether it is possible to improve long-term effectiveness of CBT for MS-related fatigue with MS Stay Fit. TRIAL REGISTRATION: Dutch Trial Register (NTR6966), registered 18 January 2018 https://www.trialregister.nl/trial/6782 WORLD HEALTH ORGANIZATION (WHO) TRIAL REGISTRATION DATA SET: All items from the WHO Trial Registration Data Set can be found within the protocol.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Houniet-de Gier M, Beckerman H, van Vliet K, et al. Testing non-inferiority of blended versus face-to-face cognitive behavioural therapy for severe fatigue in patients with multiple sclerosis and the effectiveness of blended booster sessions aimed at improving long-term outcome following both therapies: study protocol for two observer-blinded randomized clinical trials. Trials. 2020. PMID: 31959235. doi:10.1186/s13063-019-3825-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。